March 26, 2020 / 4:06 AM / 14 days ago

BRIEF-Cipla Ltd -Gets Final Approval For Generic Version Of Astrazeneca Pharma's Nexium

March 26 (Reuters) - Cipla Ltd:

* CIPLA LTD -RECEIVES FINAL APPROVAL FOR GENERIC VERSION OF ASTRAZENECA PHARMACEUTICAL’S NEXIUM® (ESOMEPRAZOLE FOR ORAL SUSPENSION 10MG, 20MG AND 40MG) Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below